Westminster Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for WESTMINSTER PHARMS, and what generic and branded alternatives to WESTMINSTER PHARMS drugs are available?
WESTMINSTER PHARMS has three approved drugs.
Drugs and US Patents for Westminster Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Westminster Pharms | MIGLITOL | miglitol | TABLET;ORAL | 203965-003 | Feb 24, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Westminster Pharms | EPLERENONE | eplerenone | TABLET;ORAL | 207842-001 | Oct 25, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Westminster Pharms | EPLERENONE | eplerenone | TABLET;ORAL | 207842-002 | Oct 25, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.